Matinas BioPharma
MTNB
#9903
Rank
ยฃ2.68 M
Marketcap
ยฃ0.54
Share price
25.35%
Change (1 day)
-94.59%
Change (1 year)

Revenue for Matinas BioPharma (MTNB)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of ยฃ0.86 Million a decrease over the revenue in the year 2022 that were of ยฃ2.63 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Matinas BioPharma from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 ยฃ0.86 M-67.36%
2022 ยฃ2.63 M10574.51%
2021 ยฃ0.02 M-78.74%
2020 ยฃ0.11 M69.6%
2019 ยฃ0.06 M-27.4%
2018 ยฃ0.09 M-14.82%
2017 ยฃ0.11 M
2016 N/A-100%
2015 ยฃ0.13 M
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA